- Investing Ideas
- Canadian Pharmaceuticals & Biotech Healthy potentially undervalued
Canadian Pharmaceuticals & Biotech Healthy potentially undervalued
Results
9
Companies which are potentially undervalued and in an acceptable financial position.
9 companies
High Tide
Market Cap: CA$277.6m
Engages in the cannabis retail business in Canada, the United States, and internationally.
HITI
CA$3.16
7D
-1.9%
1Y
-15.1%
Verano Holdings
Market Cap: CA$519.4m
Operates as a vertically integrated multi-state cannabis operator in the United States.
VRNO
CA$1.43
7D
-15.4%
1Y
-4.0%
Curaleaf Holdings
Market Cap: CA$2.6b
Produces and distributes cannabis products in the United States and internationally.
CURA
CA$3.31
7D
1.2%
1Y
59.9%
Medexus Pharmaceuticals
Market Cap: CA$92.4m
Operates as a pharmaceutical company in Canada and the United States.
MDP
CA$2.86
7D
0.7%
1Y
-7.4%
Cresco Labs
Market Cap: CA$620.4m
Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany.
CL
CA$1.38
7D
-3.5%
1Y
3.8%
TerrAscend
Market Cap: CA$307.7m
TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States.
TSND
CA$0.83
7D
-9.8%
1Y
0%
Aurora Cannabis
Market Cap: CA$276.2m
Engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally.
ACB
CA$4.87
7D
2.1%
1Y
-45.5%
Trulieve Cannabis
Market Cap: CA$1.5b
Operates as a cannabis retailer.
TRUL
CA$8.67
7D
-8.5%
1Y
34.6%
Organigram Global
Market Cap: CA$235.1m
Engages in the production and sale of cannabis and cannabis-derived products in Canada.
OGI
CA$1.74
7D
-17.1%
1Y
-3.9%